Modeling Multivariate Distributions of Lipid Panel Biomarkers for Reference Interval Estimation and Comorbidity Analysis. [PDF]
Velev J +4 more
europepmc +1 more source
Point and Interval Estimation for some financial performance measures
Lucio De Capitani, M Zenga
openalex +1 more source
Impact of Asymptomatic Intracranial Hemorrhage on Outcome After Endovascular Stroke Treatment
ABSTRACT Background Endovascular treatment (EVT) achieves high rates of recanalization in acute large‐vessel occlusion (LVO) stroke, but functional recovery remains heterogeneous. While symptomatic intracranial hemorrhage (sICH) has been well studied, the prognostic impact of asymptomatic intracranial hemorrhage (aICH) after EVT is less certain ...
Shihai Yang +22 more
wiley +1 more source
Post-mortem Interval Estimation Through Entomology Using Calliphorid Flies: A Case Series. [PDF]
Singh A, S Y, Bhute AR, Jangid A.
europepmc +1 more source
The 'ForensOMICS' approach for postmortem interval estimation from human bone by integrating metabolomics, lipidomics, and proteomics. [PDF]
Bonicelli A +6 more
europepmc +1 more source
Neuroinflammation in GAD65 Antibody‐Associated Epilepsy Measured Using [18F]DPA‐714 PET/MRI
ABSTRACT The timing for initiating immunotherapy in patients with glutamic acid decarboxylase 65 (GAD65) antibody‐associated epilepsy is a challenge. We used the translocator protein radioligand [18F]DPA‐714 and PET to evaluate brain microglial activation.
Jingjing Chen +10 more
wiley +1 more source
Advancing time-since-interval estimation for clandestine graves: a forensic ecogenomics perspective into burial and translocation timelines using massively parallel sequencing. [PDF]
de Bruyn C +4 more
europepmc +1 more source
Accurate Confidence and Bayesian Interval Estimation for Non-centrality Parameters and Effect Size Indices. [PDF]
Kang K +6 more
europepmc +1 more source
Interval attenuation estimation [PDF]
Hafiz Alshammery, M. N. Toksoz
openaire +1 more source
Fluid Biomarkers of Disease Burden and Cognitive Dysfunction in Progressive Supranuclear Palsy
ABSTRACT Objective Identifying objective biomarkers for progressive supranuclear palsy (PSP) is crucial to improving diagnosis and establishing clinical trial and treatment endpoints. This study evaluated fluid biomarkers in PSP versus controls and their associations with regional 18F‐PI‐2620 tau‐PET, clinical, and cognitive outcomes.
Roxane Dilcher +10 more
wiley +1 more source

